Santa Clara, CA, United States of America

Madhurima Chatterjee

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Madhurima Chatterjee. Retrieved from https://idiyas.com/inventor/madhurima-chatterjee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal3 out of 834,453 
Other
 patents

Years Active: 2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Madhurima Chatterjee

Introduction

Madhurima Chatterjee is an accomplished inventor based in Santa Clara, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in developing compositions aimed at treating health conditions associated with elevated glucose levels. With a total of 3 patents to her name, her work is paving the way for advancements in diabetes management.

Latest Patents

Madhurima's latest patents include two pharmaceutical compositions, Mix A and Mix B, both designed to address health issues related to elevated glucose levels. Mix A demonstrates a threefold decrease in α-amylase inhibition, alongside an increase in insulin secretion and glucose uptake by cells. These effects were observed when compared to control cells, showing a significant improvement in managing glucose levels. Similarly, Mix B exhibits comparable results, highlighting its potential in enhancing insulin secretion and glucose uptake, thus offering promising solutions for individuals facing glucose-related health challenges.

Career Highlights

Throughout her career, Madhurima has focused on innovative solutions that combine naturally occurring substances and vitamins to create effective pharmaceutical compositions. Her dedication to research and development has led to breakthroughs that could significantly impact the treatment of diabetes and related conditions.

Collaborations

Madhurima has collaborated with notable professionals in her field, including Matthias W Rath and Aleksandra Niedzwiecki. These partnerships have fostered an environment of innovation and shared knowledge, further enhancing the quality and impact of her work.

Conclusion

Madhurima Chatterjee's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of diabetes treatment. Her patents reflect a commitment to improving health outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…